
Bioorganic and Medicinal Chemistry Letters p. 1867 - 1872 (1998)
Update date:2022-09-26
Topics:
Hulme, Christopher
Moriarty, Kevin
Miller, Bruce
Mathew, Rose
Ramanjulu, Mercy
Cox, Paul
Souness, John
Page, Ken M.
Uhl, Joanne
Travis, Jeffrey
Huang, Fu-Chih
Labaudiniere, Richard
Djuric, Stevan W.
This communication describes the synthesis and in vitro evaluation of a novel potent series of phosphodiesterase type (IV) (PDE4) inhibitors. The compounds described contain an indole moiety which replaces the 'rolipram- like' 3-methoxy-4-cyclopentoxy motif. Several of the compounds presented possess low nanomolar IC50's for PDEIV inhibition. In vivo activities determined from measurement of serum TNF-α levels in LPS challenged mice (mouse endotoxemia model) are also reported.
View MoreZhejiang Tianyu Pharmaceutical Co., Ltd.
Contact:+86-576-84177669, 89189665,89189688,84168770
Address:Jiangkou Development Zone, Huangyan, Taizhou City, Zhejiang
Shanghai Norky Pharmaceutical Co., LTD.
website:http://www.norkypharm.com
Contact:86-21-61075300
Address:1165 Jiangning Road, Office 1502, Shanghai, China
website:http://www.np-chem.com
Contact:0086-25-52346877
Address:199, Jian Ye Road, Nanjing, China
XI'AN CHUKANG BIOTECHNOLOGY CO.,LTD
Contact:29-63685658 63685359
Address:Room 3-1202,Building 1,Oriental oasis,East of Xianning Road,Xi'an,Shaanxi 710043 P.R.China
Contact:+86-371-86058576
Address:NO.32, Jingsan Road, Zhengzhou, China
Doi:10.1016/0584-8539(96)01680-7
(1996)Doi:10.1002/ardp.19973301205
(1997)Doi:10.3390/ijms20215481
(2019)Doi:10.1007/BF02253171
(1997)Doi:10.1039/DT9920002651
(1992)Doi:10.1055/s-1995-3887
(1995)